1 study found for:    19718025 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Lapatinib in Stage IV Melanoma With ERBB4 Mutations
Condition: Malignant Melanoma
Intervention: Drug: Lapatinib

Indicates status has not been verified in more than two years